• PPARγ, Macrophage Polarization, and DSS-Induced IBD

  2026-10-06

  A 2025 study links PPARγ activation with reduced M1-like macrophage signaling, enhanced M2-associated markers, and improved disease features in a DSS-induced inflammatory bowel disease model. Its central contribution is a mechanistic framework connecting macrophage polarization to reciprocal STAT-1 and STAT-6 signaling, while its preclinical design limits direct conclusions about human IBD or other PPARγ-related disease areas.

• Dorsomorphin 2HCl: Reading AMPK Evidence

  2026-10-06

  Dorsomorphin 2HCl is an AMPK inhibitor that can help test whether AMPK contributes to metabolic phenotypes. This evidence-focused guide explains how to interpret its use in the 2025 LP.P101 mouse study while accounting for BMP signaling, hepcidin biology, and pharmacological limitations.

• DNMT3B and Neuroendocrine Plasticity in Prostate Cancer

  2026-10-05

  The reference study identifies DNMT3B as a driver of therapy-associated lineage plasticity, stemness, and aggressive neuroendocrine prostate cancer progression. Its evidence links DNMT3B to disease initiation and maintenance and reports that pharmacologic inhibition reduces tumor growth in vivo, while important questions about clinical translation and model relevance remain.

• p21 mRNA–LNP Delivery in Bladder Cancer

  2026-10-05

  A source-grounded overview of intravesical p21 mRNA-loaded lipid nanoparticles for bladder cancer, covering the biological rationale, reported preclinical findings, evidence strength, translational relevance, and key limitations.

• SR-202: Five Questions About PPARγ Evidence

  2026-10-04

  A source-grounded overview of SR-202, PPARγ biology, and what recent intestinal inflammation research does—and does not—show about mechanism, evidence quality, translational scope, and limitations.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-10-03

  A 2025 GeroScience study presents a genetically sensitized Saccharomyces cerevisiae platform for detecting TOR/mTOR pathway inhibitors with substantially greater sensitivity than a wild-type background. The work identifies activity for established inhibitors and aminophylline while showing that several other tested compounds, including an SGLT2-directed metabolic compound, produced no evidence of TOR inhibition in this yeast model.

• SR-202: A Causal Tool for PPARγ Biology

  2026-10-02

  SR-202 is a selective PPARγ antagonist for testing whether receptor activity drives adipogenesis, macrophage polarization, and metabolic inflammation. This article connects SR-202 to a recent intestinal inflammation study and explains how to use pathway-blocking experiments for stronger causal interpretation.

• Trelagliptin and Cognitive Impairment in Diabetic Rats

  2026-10-01

  The reference study shows that trelagliptin improved spatial learning, memory, inflammation, and neuronal structure in streptozotocin/high-fat-diet diabetic rats. Its main innovation is linking cognitive benefits to concurrent suppression of inflammatory signaling and activation of the PI3K/Akt/GSK-3β pathway, while also highlighting the need for further translational validation.

• circ_0042103/TAF15/NER Axis in Pulpitis

  2026-10-01

  The reference study identifies a circ_0042103/TAF15/NER axis that links circular RNA activity with DNA double-strand-break signaling and inflammation in dental pulp stem cells. Its integrated tissue, transcriptomic, and molecular-interaction design provides a framework for testing how circRNAs influence repair capacity during pulpitis, while also highlighting the need for rigorous circular RNA validation.

• KX2-391 Analogues and Oncogenic Kinase SAR

  2026-09-30

  This 2022 Frontiers in Oncology study used scaffold hopping to test whether KX2-391 analogues retained Src inhibition and tubulin disruption or acquired different kinase activities. The lead analogue 4e preferentially affected leukemia models and strongly altered ERK1/2 and c-Jun kinase signaling without depending on either parental mechanism, demonstrating why analogue SAR requires broad functional profiling.

• Exendin-4: From cAMP Biology to Translation

  2026-09-30

  A mechanism-first perspective on Exendin-4 and Exenatide, linking GLP-1 receptor signaling, beta cell function research, metabolic phenotyping, and emerging yeast-expression strategies for more accessible type 2 diabetes research.

• BAY-826: Retinal Signaling for Translational Research

  2026-09-29

  BAY-826 offers a potent chemical perturbation strategy for testing angiopoietin-linked control of Müller cell signaling, PEDF production, and retinal neuron survival. This perspective connects pathway biology with assay design while separating established evidence from translational hypotheses.

• Pemetrexed as a Precision Probe in Mesothelioma

  2026-09-29

  Pemetrexed can be more than a cytotoxic control: its multi-target antifolate activity provides a mechanistic entry point for connecting folate stress, nucleotide depletion, replication vulnerability, and DNA-repair phenotypes. This thought-leadership guide translates evidence from malignant pleural mesothelioma research into practical assay design, biomarker strategy, and translational positioning.

• Bifendate Blocks Autophagy and Lipid Accumulation

  2026-09-28

  The reference study shows that bifendate inhibits autophagy at several mechanistically distinct stages, including autophagosome–lysosome fusion, lysosome acidification, and autophagic lysosome reformation. It also reduces oleic acid-induced lipid droplet accumulation, providing a more nuanced basis for interpreting bifendate in liver-disease and lipid-metabolism models.

• TH287 MTH1 Inhibitor for Cancer Radiosensitization

  2026-09-28

  TH287 provides a practical way to test whether blocking oxidized-nucleotide cleanup can amplify radiation-associated stress in cancer cells. A castration-resistant prostate cancer study highlights a schedule-sensitive effect: irradiation 12 hours after TH287 produced stronger responses than later schedules in PC-3 and DU-145 cells.

8720 records 2/582 page Previous Next 12345 下5页 Last page